Companies: 10,795·Total market cap: $144.5T
ProPhase Labs, Inc.

ProPhase Labs, Inc.

PRPHNASDAQHealthcare● Active
$0.10
$-0.01(-9.09%)
Market Cap$473701
P/E Ratio
52W High$6.7
52W Low$0.07
Overview

ProPhase Labs, Inc.(PRPH)· 资产负债表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PRPH · 截至 2026-06-10

财务报表

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$0.09M$0.68M$4.74M$17.44M$17.51M
Net Receivables$1.54M$20.06M$35.81M$37.05M$37.71M
Inventory$0.00M$1.14M$2.29M$3.98M$4.60M
Total Current Assets$3.15M$30.64M$47.59M$60.83M$61.32M
PP&E Net$0.00M$11.62M$14.90M$11.35M$10.35M
Goodwill$3.97M$5.23M$5.23M$5.71M$5.71M
Intangible Assets$7.17M$9.75M$12.33M$8.47M$10.85M
Total Assets$59.87M$63.20M$91.93M$87.65M$89.30M
Liabilities
Short-Term Debt$5.16M$6.57M$2.79M$0.30M$0.66M
Accounts Payable$12.96M$13.72M$8.64M$5.91M$7.03M
Total Current Liabilities$53.08M$32.13M$20.86M$16.07M$15.52M
Long-Term Debt$0.00M$11.65M$7.33M$2.40M$10.04M
Total Liabilities$56.36M$55.85M$42.54M$24.02M$30.67M
Stockholders Equity
Retained Earnings($73.14M)($58.39M)($5.03M)$11.75M$2.64M
Total Stockholders Equity$3.51M$7.35M$49.38M$63.63M$58.63M
Total Liab & Equity(computed)$59.87M$63.20M$91.93M$87.65M$89.30M
Debt Summary
Total Debt$8.62M$24.57M$18.46M$6.96M$14.90M
Net Debt$8.53M$23.89M$16.85M($2.15M)$6.24M

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解ProPhase Labs, Inc.

关于ProPhase Labs, Inc.(PRPH)资产负债表

ProPhase Labs, Inc.总资产$0.06B,现金及短期投资$0.00B,总负债$0.06B,总债务$0.01B,股东权益$0.00B。

常见问题

PRPH · 4 问

ProPhase Labs, Inc.总债务$0.01B,净债务$0.01B。

PRPH total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10